Enhancer ID: | E_01_0129 |
Species: | human |
Position : | chr5:151027281-151029281 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Systemic lupus erythematosus |
Pubmed ID: | 31804013 |
Enhancer experiment: | Dual luciferase reporter assay, electrophoretic mobility shift assay, QRT PCR, Western blot, and pulldown |
Enhancer experiment description: | Hypomorphic TNIP1 expression results from the combined concordant and opposing effects of multiple risk variants carried on the TNIP1 risk haplotype, with the strongest regulatory effect in B lymphoid lineage cells. |
Target gene : | -- |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Hypomorphic TNIP1 expression results from the combined concordant and opposing effects of multiple risk variants carried on the TNIP1 risk haplotype, with the strongest regulatory effect in B lymphoid lineage cells. |
TF name : | TNIP1 |
TF experiment: | ??????????????????qRT-PCR?Western blot?pulldown |
TF experiment description: | Hypomorphic TNIP1 expression results from the combined concordant and opposing effects of multiple risk variants carried on the TNIP1 risk haplotype, with the strongest regulatory effect in B lymphoid lineage cells. |
Enhancer function : | Hypomorphic TNIP1 expression results from the combined concordant and opposing effects of multiple risk variants carried on the TNIP1 risk haplotype, with the strongest regulatory effect in B lymphoid lineage cells. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Hypomorphic TNIP1 expression results from the combined concordant and opposing effects of multiple risk variants carried on the TNIP1 risk haplotype, with the strongest regulatory effect in B lymphoid lineage cells. |
SNP ID: | -- |